Lansing Street Advisors disclosed in a recent SEC filing that it established a new stake in BlackRock ETF Trust - iShares International Country Rotation Active ETF (NASDAQ:CORO) during the first quarter of 2026. The investment firm acquired 233,608 shares, with the estimated transaction value at $7.51 million based on the quarter’s average share price. The quarter-end position value also increased...
Lansing Street Advisors disclosed in a recent SEC filing that it established a new stake in BlackRock ETF Trust - iShares International Country Rotation Active ETF (NASDAQ:CORO) during the first quarter of 2026. The investment firm acquired 233,608 shares, with the estimated transaction value at $7.51 million based on the quarter’s average share price. The quarter-end position value also increased by $7.51 million, reflecting the new stake and any price movement. The BlackRock ETF Trust - iShares International Country Rotation Active ETF is designed to provide investors with access to a diversified portfolio of international equities by rotating country allocations based on quantitative models. Continue reading
"Low Hire, No Fire": Jobless Claims Unexpectedly Plunge To Record Low We have gone from a " low hire, low fire" economy to " AI chatbot hire, no fire ." We joke, but really there is no other way to explain what is going on here: this morning the Dept of Labor reported that in the week ended April 25, jobless claims fell 26k to 189k (from an upward revised 215k), compared with median est. 212k. And...
"Low Hire, No Fire": Jobless Claims Unexpectedly Plunge To Record Low We have gone from a " low hire, low fire" economy to " AI chatbot hire, no fire ." We joke, but really there is no other way to explain what is going on here: this morning the Dept of Labor reported that in the week ended April 25, jobless claims fell 26k to 189k (from an upward revised 215k), compared with median est. 212k. And... are you sitting down ... this was the lowest weekly jobless print on record . With the est. range at 205k-228k, today's print was not only far below the lowest estimate, but a 6 sigma miss to estimates. While one can normally blame this on seasonal adjustments, the unadjusted number also plunged to just 179K in the last week. Continuing claims also fell 23k to 1.785m in the week ending April 18. This was the lowest since early 2024. Those wondering what was behind the unprecedented drop in claims, the answer appears to be a crash in New York State initial claims. Tyler Durden Thu, 04/30/2026 - 09:28
(RTTNews) - While reporting financial results for the first quarter on Thursday, Albany International Corp. (AIN) provided its adjusted earnings and revenue guidance for the second quarter.
(RTTNews) - While reporting financial results for the first quarter on Thursday, Albany International Corp. (AIN) provided its adjusted earnings and revenue guidance for the second quarter.
Establishment Labs ( ESTA ) entered a $300M senior secured term loan with Oaktree Capital Management. The facility refinances existing debt and extends maturity to 2031, improving financial flexibility. The loan is split into $265M (refinancing tranche) and $35M (growth capital tranche). The agreement features a fixed interest rate with potential reductions tied to leverage targets. The deal suppo...
Establishment Labs ( ESTA ) entered a $300M senior secured term loan with Oaktree Capital Management. The facility refinances existing debt and extends maturity to 2031, improving financial flexibility. The loan is split into $265M (refinancing tranche) and $35M (growth capital tranche). The agreement features a fixed interest rate with potential reductions tied to leverage targets. The deal supports positive free cash flow expected in H2 2026 and future expansion. More on Establishment Labs Establishment Labs Holdings Inc. (ESTA) Q4 2025 Earnings Call Transcript Establishment Labs: The Pivot From Growth To Profitable Scale Establishment Labs targets at least 25% revenue growth in 2026 while expanding minimally invasive platforms Establishment Labs GAAP EPS of -$0.09 beats by $0.13, revenue of $64.62M beats by $0.5M Seeking Alpha’s Quant Rating on Establishment Labs
AVITA Medical ( RCEL ) said on Thursday it appointed Cary Vance its CEO, effective immediately, after serving in the role on an interim basis since October 2025. Vance will continue as a board member, while Jan Stern Reed was named chair of the board, also effective immediately. The company said the appointment follows a formal search process. "The Board unanimously concluded that Cary is the righ...
AVITA Medical ( RCEL ) said on Thursday it appointed Cary Vance its CEO, effective immediately, after serving in the role on an interim basis since October 2025. Vance will continue as a board member, while Jan Stern Reed was named chair of the board, also effective immediately. The company said the appointment follows a formal search process. "The Board unanimously concluded that Cary is the right leader to serve as CEO on a permanent basis,” said newly appointed Chair Reed. Vance, a healthcare executive with three decades of experience, said the company is focused on scaling adoption of its products and driving consistent performance as it builds momentum in the acute wound care market. More on AVITA Medical AVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Transcript AVITA Medical: Why The BARDA Rally Changes Nothing AVITA Medical, Inc. (RCEL) Discusses Financial Performance, Sales Strategy, and Reimbursement Progress Transcript AVITA Medical rises as Cohealyx halves time to skin grafting AVITA Medical wins BARDA contract worth up to $25.5M
Lobro78/iStock Editorial via Getty Images Apple's ( AAPL ) May 1 weekly options are pricing a roughly 4% post-earnings move ahead of the iPhone maker’s fiscal second-quarter report after Thursday’s market close, with the 270 to 275 area emerging as the main battleground into Friday expiration. With shares closing at $270.17 per share on Wednesday, the options chain suggested traders were bracing f...
Lobro78/iStock Editorial via Getty Images Apple's ( AAPL ) May 1 weekly options are pricing a roughly 4% post-earnings move ahead of the iPhone maker’s fiscal second-quarter report after Thursday’s market close, with the 270 to 275 area emerging as the main battleground into Friday expiration. With shares closing at $270.17 per share on Wednesday, the options chain suggested traders were bracing for a move of roughly $10.50 to $10.70 by the end of the week. The 270 straddle was worth about $10.45 on mid-pricing, while the 272.5 straddle was worth about $10.70, implying a first-pass post-report range of roughly $260 to $281. The structure leaned more toward upside participation than defensive positioning, with the market focused on whether Apple ( AAPL ) can break through 275 to 280 or lose the 260 area after results. The heaviest activity was concentrated on the call side near and above spot. The 270 call traded 16,846 contracts, while the 275 call traded 11,013 and the 280 call traded 7,251. Open interest was heavily stacked above the stock, led by the 275 call with 22,435 contracts. The put side showed activity below spot, with the 255 put trading 8,345 contracts and notable open interest at the 250 put with 17,644 contracts. With Tim Cook set to step down as chief executive in September, Apple’s ( AAPL ) quarterly results and subsequent earnings call are expected to center around the company's leadership transition, as well as its artificial intelligence strategy under incoming top boss John Ternus. Wall Street expects the iPhone maker to post EPS of $1.94 a share on revenue of $109.58B. More on Apple Apple: Tim Cook Exits At The Top Apple: A New Boss And A New And Higher Dividend (Rating Upgrade) Wall Street Brunch: Five Of The Mag 7 Ride Into Earnings Town Apple plans to add Siri mode to camera app and new visual AI tools to iOS 27: report Apple’s leadership transition, AI vision under new CEO Ternus to steal spotlight during earnings
Lobro78/iStock Editorial via Getty Images Apple's ( AAPL ) May 1 weekly options are pricing a roughly 4% post-earnings move ahead of the iPhone maker’s fiscal second-quarter report after Thursday’s market close, with the 270 to 275 area emerging as the main battleground into Friday expiration. With
Lobro78/iStock Editorial via Getty Images Apple's ( AAPL ) May 1 weekly options are pricing a roughly 4% post-earnings move ahead of the iPhone maker’s fiscal second-quarter report after Thursday’s market close, with the 270 to 275 area emerging as the main battleground into Friday expiration. With
U. S. stock futures are pointing to a stronger start on Thursday, suggesting markets could move higher after finishing the previous session with little overall direction.
U. S. stock futures are pointing to a stronger start on Thursday, suggesting markets could move higher after finishing the previous session with little overall direction.
Gemini Space Station已获得美国商品期货交易委员会(CFTC)批准,可运营其自有的受监管衍生品清算所。这一举措使温克尔沃斯兄弟旗下的这家加密货币交易所能够自行清算和结算交易,而无需依赖外部基础设施,从而对其预测市场产品的运作和规模化获得更大的控制权。 此消息推动该公司股价在盘前交易中上涨了2.5%。 Gemini总裁兼联合创始人卡梅伦·温克尔沃斯在接受CNBC独家采访时表示:“考...
Gemini Space Station已获得美国商品期货交易委员会(CFTC)批准,可运营其自有的受监管衍生品清算所。这一举措使温克尔沃斯兄弟旗下的这家加密货币交易所能够自行清算和结算交易,而无需依赖外部基础设施,从而对其预测市场产品的运作和规模化获得更大的控制权。 此消息推动该公司股价在盘前交易中上涨了2.5%。 Gemini总裁兼联合创始人卡梅伦·温克尔沃斯在接受CNBC独家采访时表示:“考虑到预测市场以及未来加密衍生品的巨大机遇,端到端地拥有和运营市场是非常强大的。” 此次获批标志着Gemini在构建全方位合规衍生品平台的道路上迈出了关键一步。据悉,Gemini旗下的Olympus部门获得的这张衍生品清算组织(DCO)牌照,使其能够作为内部清算机构,独立处理结算、风险管理及抵押品管理。这彻底改变了之前必须依赖第三方清算机构的模式,有望显著降低运营成本并提升交易效率。 早在2025年12月,Gemini的一家关联实体已获得CFTC颁发的指定合约市场(DCM)牌照,并借此推出了预测市场。此次获得DCO牌照,意味着Gemini现在集齐了推出和清算受监管衍生品(包括期货、期权和永续合约)所需的两张核心牌照。 目前,Gemini正在进一步申请期货佣金商(FCM)牌照,以完善其CFTC资质布局,旨在与Kraken、Coinbase等竞争对手在美国合规衍生品市场展开全面竞争。此举被市场视为Gemini从单一的加密货币交易所向多元化金融市场平台转型的重要一步。 责任编辑:张俊 SF065
如今,电子产品涨价已经不是什么新鲜事了,存储成本一路飙涨,造成手机、笔记本、游戏机等各种需要存储部件的产品都顶不住压力纷纷跟涨。以Mac mini M4来说,目前苹果官网已经无法下单,各大电商平台上这台设备早已没有了当年3000元以下的百亿补贴「神价」,连二手价都涨到了3500元左右。 当然,Mac mini M4供不应求,还有一个很重要的原因——龙虾热。年初OpenClaw热潮席卷而来,「养虾」...
如今,电子产品涨价已经不是什么新鲜事了,存储成本一路飙涨,造成手机、笔记本、游戏机等各种需要存储部件的产品都顶不住压力纷纷跟涨。以Mac mini M4来说,目前苹果官网已经无法下单,各大电商平台上这台设备早已没有了当年3000元以下的百亿补贴「神价」,连二手价都涨到了3500元左右。 当然,Mac mini M4供不应求,还有一个很重要的原因——龙虾热。年初OpenClaw热潮席卷而来,「养虾」成为全世界用户热议的话题。而集体积小巧、功耗低、性能强、系统支持友好等一系列优点于一身的Mac mini M4,迅速成为养虾户们青睐的对象。 (图源:苹果) 现在,龙虾热潮已经退去了不少,那些专门为了养虾而入手Mac mini的人,还在继续用他们部署的龙虾吗?带着这样的好奇,我们找了几位用户,了解当下的真实情况。 新媒体编辑:龙虾已放弃,「爱马仕」才是新欢 大学同学小晨现在是一名自媒体编辑,平时主要负责汽车领域。龙虾潮到来时,他抱着一种不能落伍的心态来问过我,部署龙虾是不是Mac mini最合适。但那个时候,Mac mini M4已经涨价了,小晨最后花2000多买了台二手Mac mini M2。 部署好龙虾后,小晨还会时不时吐槽一波,OpenClaw经常会掉线,有时候在外地出差发现联动的飞书机器人没反应,就知道办公室的龙虾宕机了。这种时候,小晨就会让同事帮忙重启下,这个场面就显得有些哭笑不得。 (图源:雷科技) 而现在,小晨却表示,已经放弃龙虾了,找到的替代品是「爱马仕」。具体来说,它其实就是最近流行的Hermes Agent。「爱马仕」是一个开源智能体,主打自动进化能力。比如,你通过它完成一项比较复杂的任务后,「爱马仕」会提炼出其中可以复用的技能并保存,用得越多,它就越聪明。 小晨认为,「爱马仕」更轻量,用起来更方便。他表示,OpenClaw就好比是一个能运行很多智能体的全能平台,要好用得自己调;而「爱马仕」则是一个功能更聚焦的智能体,在小场景里做得更好。 目前,他用「爱马仕」的主要场景就是把它当成智能助理,并且接入到飞书里。平时,小晨会把自己写的文档丢给他记录,或者把看到的资料也扔给它,等于把它当智能收藏夹用,后续的任务里如果用得到这些资料,AI自己就会调用。 (图源:雷科技) 另外,小晨还会让它做早报发微博,平时的工作流简化了,效率也更高了。 (图源:雷科技) 金融民...
TwilightShow/iStock Unreleased via Getty Images Japan Smaller Capitalization Fund ( JOF ) is a closed-end fund , offering exposure to Japanese small-cap equities. The average market capitalisation of the companies in USD terms happens to be roughly around ~$1.05 billion . As is the case with many of the CEFs, this fund presently trades at a discount from its NAV. Interestingly, however, the fund h...
TwilightShow/iStock Unreleased via Getty Images Japan Smaller Capitalization Fund ( JOF ) is a closed-end fund , offering exposure to Japanese small-cap equities. The average market capitalisation of the companies in USD terms happens to be roughly around ~$1.05 billion . As is the case with many of the CEFs, this fund presently trades at a discount from its NAV. Interestingly, however, the fund has distributed around $0.5322 for FY25. At the current market price of ~$11 , this is a distribution yield of ~4.8%. This was done under their level distribution plan, LDP . It is important to note that JOF is not an income-focused fund but rather attempts to deliver returns in long-term capital appreciation . The dividend yields might fluctuate, and this remains primarily an investment proposition for investing in Japanese small-cap equities. More importantly, however, it is the current trajectory of Japanese equities that makes it a closer look. We are aware that historically, Japanese equities have underperformed severely on both an absolute and relative basis. However, the stance seems to be shifting from recent times. Over the last couple of years, Japanese equities saw a significant interest among the investors. Moreover, even after the recent up-move, Japanese equities on a quantitative basis are still fairly cheap on a standalone as well as relative basis. There have been genuine structural reasons for the same, such as lower returns on equities, lacking corporate governance standards, and regulatory landscapes, which have resulted in structural underperformance. However, presently ground has started shifting, with not only more investors starting to look into Japanese equities by virtue of their cheapness along with elevated valuation levels of broader equities such as the S&P 500, but in addition, there have been fundamental developments undergoing as well. As a matter of fact, the Tokyo Stock Exchange sometime back issued a directive that it would start publicly ...
Zenas BioPharma ( ZBIO ) added ~8% in the premarket on Thursday after the chief executive of the clinical-stage biotech continued a recent trend of buying shares of the company, adding more than $1M worth of stock as part of his latest insider purchase. CEO Lonnie Moulder disclosed two insider transactions in a regulatory filing on Wednesday, indicating that he purchased 60K shares of Zenas BioPha...
Zenas BioPharma ( ZBIO ) added ~8% in the premarket on Thursday after the chief executive of the clinical-stage biotech continued a recent trend of buying shares of the company, adding more than $1M worth of stock as part of his latest insider purchase. CEO Lonnie Moulder disclosed two insider transactions in a regulatory filing on Wednesday, indicating that he purchased 60K shares of Zenas BioPharma ( ZBIO ) at an average price of $17.79 apiece. Moulder, the founder and chairman of Zenas ( ZBIO ), has increased his stake in the company to nearly 1.8M shares following the transactions conducted on Tuesday and Wednesday. From January to March, Moulder added nearly $3.7M worth of company stock in three separate transactions worth more than $1M each. The purchases come at a time when the Waltham, Massachusetts-based biotech is awaiting mid-stage trial data for its lead asset, obexelimab, targeted at an autoimmune condition called systemic lupus erythematosus, later this year. More on Zenas BioPharma, Inc. Zenas BioPharma's Key Milestones And Market Context: Holding Through The BLA Zenas BioPharma prices $300M capital raise in dual offering Zenas BioPharma announces concurrent public offerings of convertible senior notes and common stock Seeking Alpha’s Quant Rating on Zenas BioPharma, Inc. Historical earnings data for Zenas BioPharma, Inc.
SweetBunFactory/iStock via Getty Images Wolfspeed ( WOLF ) has named Brad Kohn as its new Chief Legal and Global Affairs Officer and Sonja Burfeind as Vice President, Communications. Kohn will join from May 11, overseeing global legal, compliance, government affairs, and public policy engagement functions. He has more than 20 years of experience as a general counsel across multiple public companie...
SweetBunFactory/iStock via Getty Images Wolfspeed ( WOLF ) has named Brad Kohn as its new Chief Legal and Global Affairs Officer and Sonja Burfeind as Vice President, Communications. Kohn will join from May 11, overseeing global legal, compliance, government affairs, and public policy engagement functions. He has more than 20 years of experience as a general counsel across multiple public companies, including a previous stint at Wolfspeed. Burfeind will join as VP on July 1, leading the silicon carbide technology company’s global communications strategy, including public relations and sales and marketing communications. She has more than 20 years of experience across technology, automotive, consumer, and media industries. She last held senior communications leadership roles at Infineon ( IFNNY ) ( IFNNF ). “These appointments reflect our continued investment in leadership that enhances Wolfspeed’s ability to engage effectively with customers, shareholders, and policymakers,” CEO Robert Feurle said. “Brad and Sonja bring deep expertise and proven results that will support our strategy and help amplify Wolfspeed’s influence globally.” More on Wolfspeed, Inc. Wolfspeed: Still Not Convinced After The Bankruptcy (Earnings Preview) Wolfspeed: Persistent Operational Challenges Offset By Massive Tax Refund - Hold Wolfspeed, Inc. 2026 Q2 - Results - Earnings Call Presentation Wolfspeed closes on refinancing strategy; reduces senior note balance by $475M Wolfspeed falls after weak outlook as analysts mull 'lackluster" demand in EV market